Clinical Trials Logo

Specific Phobia clinical trials

View clinical trials related to Specific Phobia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05839431 Recruiting - Clinical trials for Autism Spectrum Disorder

Virtual Reality for Youth Phobias

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of virtual reality (VR) delivered exposure therapy for youth with phobias or social anxiety, with and without autism spectrum disorder. The study team is also interested in collecting information to better understand phobias and social anxiety.

NCT ID: NCT04563390 Recruiting - Specific Phobia Clinical Trials

Effectiveness of a Projection-based Augmented Reality Exposure System in Treating Cockroach Phobia.

Start date: November 1, 2020
Phase: N/A
Study type: Interventional

The main aim of this study is to validate and test the clinical effectiveness of the projection-based augmented reality system in cockroach phobia exposure therapy through an RCT that includes three conditions: (i) projection-based augmented reality therapy, (ii) usual treatment (in vivo exposure), (iii) waiting list control. In addition, it is intended to analyze the potential of the eye-tracking technology as a tool for evaluating the clinical effectiveness in cockroach phobia treatment.

NCT ID: NCT03917550 Recruiting - Depression Clinical Trials

RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression

RECOVERY
Start date: March 18, 2019
Phase: N/A
Study type: Interventional

To investigate the efficacy and acceptability of a guided internet delivered transdiagnostic intervention, targeting mild to moderate clinical symptoms of anxiety and depression and emphasizing the changes taking place at the level of the structures of the self.

NCT ID: NCT02739607 Recruiting - Depression Clinical Trials

Internet-delivered Transdiagnostic Intervention for Anxiety and Depression

iTAD
Start date: April 2016
Phase: N/A
Study type: Interventional

Objectives 1. To test the effectiveness and acceptability of an augmented internet-supported transdiagnostic intervention in Romania. 2. To assess the cost-effectiveness of the Internet version of the transdiagnostic program as compared to a standard treatment/usual care.

NCT ID: NCT02305537 Recruiting - Clinical trials for Obsessive-Compulsive Disorder

Building an Outcomes Assessment Infrastructure to Assess Anxiety Treatment

Start date: October 2014
Phase: N/A
Study type: Interventional

The collection of patient self-report and diagnostic data will allow us to examine the efficacy of the treatment delivered in the McLean Anxiety Mastery Program. Using data gathered through routine clinical care, the investigators seek to explore whether patients in treatment show improvements from admission to discharge, compared to patients on the waitlist, and whether these gains are maintained three months post-discharge. The following are included as examples of some of the study's hypotheses.

NCT ID: NCT02111395 Recruiting - Autism Clinical Trials

Psychotherapy for Anxiety in Children With Autism Spectrum Disorder

TAASD
Start date: April 2014
Phase: Phase 3
Study type: Interventional

Anxiety disorders affect 40 to 50% of children with autism spectrum disorders (ASD), contributing to substantial distress and impairment. The goal of this study is to examine the effectiveness of a personalized type of psychotherapy against standard-care psychotherapy for addressing anxiety in youth with ASD.

NCT ID: NCT02085343 Recruiting - Specific Phobia Clinical Trials

Anti-phobic and Safety Behaviors in the Treatment of Acrophobia

Start date: February 2013
Phase: N/A
Study type: Interventional

This study tests whether a single session of exposure therapy may be enhanced by the addition of anti-phobic actions beyond the mere fading of safety behaviors. A total of 100 acrophobic participants will be randomly assigned to receive standard exposure therapy (EXP), exposure therapy with safety behavior fading (EXP + SBF), exposure with safety behavior fading and anti-phobic actions (EXP + SBF + AA), or to a wait-list control group (WL).